Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd. (CYTO) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
cyto · market cap & enterprise value · FMP · as of Feb 10, 2026
Core market cap & key metrics
As of Feb 10, 2026, Altamira Therapeutics Ltd. (CYTO) has a market cap — also referred to as its net worth or valuation — of $1,133,556, making it one of the top most valuable companies globally. Market Cap = $0.30 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Altamira Therapeutics Ltd. (CYTO) has a market cap — also referred to as its net worth or valuation — of $1,133,556 as of Feb 10, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Altamira Therapeutics Ltd. reached its all-time high market cap of $315,684,318.365 on Dec 31, 2015. Comparing the Altamira Therapeutics Ltd. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Altamira Therapeutics Ltd. net worth vs peers and ask how Altamira Therapeutics Ltd. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
CYTO market cap · 6 questionsAltamira Therapeutics Ltd.'s net worth — measured as market capitalization — is $1,133,556 as of Feb 10, 2026. It ranks #0 globally. Market Cap = $$0.30 (price) × shares outstanding.